Industry reports
Editor highlights

Search inside this page

All regions

Free Market Research Guides to Download

Therapy Industry Market Research Reports, April 2014

You might be interested in: therapeutics, rnai therapeutics, immunotherapy, more »

» View Public Reports

1-30 of about 700 reports

Company Report: Therapy in Canada and Belgium for Year 2014

  • Company report
  • March 2014
  • 2 pages
  • Industries: Therapy
  • Countries: Canada, Belgium

Company Report: Therapeutics for Year 2014

  • Company report
  • March 2014
  • 60 pages
  • Industries: Therapy

Company Report: Therapy in The United States for Year 2014

  • Company report
  • March 2014
  • 5 pages
  • by Corporation

... Of different cancers and infectious diseases and is designed to overcome many of the manufacturing and commercialization challenges that have impeded other personalized immunotherapies. The arcelis process ...

  • Industries: Therapy
  • Countries: United States

Company Report: Therapeutics in Canada and The United States for Year 2014

  • Company report
  • March 2014
  • 2 pages

... To announce that the united states securities and exchange commission (sec) has issued an order in the matter of pacific therapeutics ltd. &Amp;#8220;declaring registration effective pursuant to section 12(g ...

  • Industries: Therapy
  • Countries: Canada, United States, World

Pluristem Therapeutics Inc. - Company Report for Year 2014

  • Company report
  • January 2014
  • 6 pages

... Pluristem therapeutics inc. Is a clinical stage biotechnology company developing placental stem cells (plx) for multiple indications. Unlike research that aims to direct stem cell differentiation to form new ...

  • Industries: Therapy
  • Countries: United States

Company Report: Immunotherapy in The United States for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • Industries: Therapy
  • Countries: United States

Company Report: Therapy in The United States for Year 2014

  • Company report
  • January 2014
  • 2 pages
  • Industries: Therapy
  • Countries: United States

Company Report: Cancer Therapeutics for Year 2013

  • Company report
  • December 2013
  • 2 pages

... Interim analysis, including biomarker data, are being analyzed, and aveo and astellas are in discussions regarding next steps. About aveo aveo oncology (nasdaq: aveo) is a cancer therapeutics company ...

  • Industries: Therapy

Vaccination Market in Egypt

  • Industry report
  • December 2013
  • 27 pages

... vaccination delivered through campaigns Production system prod. Cycle length (days) eligible days for 1 shot (days) flock coverage with 2 shots (%) duration after 2 shots to achieve 100 ...

  • Industries: Therapy
  • Countries: Egypt

Company Report: Therapeutics in The United States for Year 2013

  • Company report
  • December 2013
  • 2 pages
  • by Corporation

... Of important milestones into the second half of 2015." Proceeds from the transactions will be used to advance the development of the company's next-generation therapies for fabry, pompe and other lysosomal ...

  • Industries: Therapy
  • Countries: United States

Company Report: Therapeutics for Year 2013

  • Company report
  • December 2013
  • 4 pages
  • by Corporation

... Five prime assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. Five prime therapeutics ...

  • Industries: Therapy

Company Report: Therapy for Year 2013

  • Company report
  • November 2013
  • 3 pages

... Migalastat hcl as a monotherapy and in combination with enzyme replacement therapy (ert) for fabry disease; and at2220 (duvoglustat hcl) in combination with ert for pompe disease. About chaperone ...

  • Industries: Therapy

Company Report: Therapy in India for Year 2013

  • Company report
  • November 2013
  • 4 pages
  • by Corporation
  • Industries: Therapy
  • Countries: India

Company Report: Therapy in The United States for Year 2013

  • Company report
  • November 2013
  • 6 pages
  • by Corporation
  • Industries: Therapy
  • Countries: United States

Company Report: Therapy in Australia for Year 2013

  • Company report
  • November 2013
  • 4 pages
  • Industries: Therapy
  • Countries: Australia

Company Report: Therapy in Kenya for Year 2013

  • Company report
  • November 2013
  • 30 pages
  • Industries: Therapy
  • Countries: Kenya

Company Report: Therapeutics in Netherlands for Year 2013

  • Company report
  • November 2013
  • 2 pages

... Late therapeutics small 5.0% Marketcap ...

  • Industries: Therapy
  • Countries: Netherlands

Company Report: Therapy in The United States for Year 2013

  • Company report
  • October 2013
  • 34 pages

... October 2013 next-generation cancer therapeutics sorrento therapeutics 2 this presentation contains "forward-looking statements" as that term is defined under the private securities ...

  • Industries: Therapy
  • Countries: United States

Company Report: Chemotherapy in Australia for Year 2013

  • Company report
  • October 2013
  • 69 pages
  • by Governmental Agency

... To as personalised medicine), increasing patient access to new therapies. There has been growth in the use of chemotherapy agents in early and advanced stages of cancer care. There has also been an increase ...

  • Industries: Therapy
  • Countries: Australia

Connecticut Innovations Inc. - Company Report for Year 2013

  • Company report
  • October 2013
  • 4 pages

... The proposed follow-on preseed investment of up to $200,000 in bioarray therapeutics, farmington. The funding will be used to continue to develop the product and other company start-up expenses. Ms. Mu ...

  • Industries: Therapy
  • Countries: United States

Company Report: Chemotherapy in Australia for Year 2013

  • Company report
  • September 2013
  • 48 pages
  • by Governmental Agency

... Who had accessed chemotherapy services, and voting members of chf who represent the views of consumers around australia. As outlined in the overview of consultation findings ...

  • Industries: Therapy
  • Countries: Australia

Company Report: Therapy for Year 2013

  • Company report
  • September 2013
  • 3 pages
  • Industries: Therapy

Company Report: Therapy in Sweden, The United States and Austria for Year 2013

  • Company report
  • September 2013
  • 12 pages
  • Industries: Therapy
  • Countries: Sweden, United States, Austria

Company Report: Therapy for Year 2013

  • Company report
  • August 2013
  • 4 pages

... Emetic chemotherapy (hec), apf530 was numerically superior to aloxi for acute- onset cinv. For each of these three indications, apf530 was shown to be statistically non-inferior to the market leader. We ...

  • Industries: Therapy

Physiotherapy Market Trends in Australia

  • Industry report
  • August 2013
  • 42 pages

... Type does not specifically identify itself as a physiotherapy practice (e.G. Sports medicine centre). physiotherapy services are provided as part of a broader range of health services delivered ...

  • Industries: Therapy
  • Countries: Australia

Company Report: Therapy in The United States and Denmark for Year 2013

  • Company report
  • August 2013
  • 2 pages

... Compound that is being studied in combination with anti- vascular endothelial growth factor (vegf) therapy for the treatment of neovascular age- related macular degeneration (wet amd). Ophthotech initiated ...

  • Industries: Therapy
  • Countries: United States, Denmark

World Pain Management Therapeutics Industry Brief

  • Industry report
  • July 2013
  • 13 pages

... In 2011, of the total pain management therapeutics market by therapeutic class. This class comprises of some of the oldest known painkillers such as diclofenac, ibuprofen and aspirin (acetylsalicylic acid ...

  • Industries: Therapy
  • Countries: World

Company Report: Therapy in Austria for Year 2013

  • Company report
  • June 2013
  • 8 pages

... Austron | june 2013 4 the therapy provided by medaustron medaustron will provide an innovative form of radiation therapy, namely ion beam therapy. In that process the tumours are irradiated with charged ...

  • Industries: Therapy
  • Countries: Austria

Company Report: Therapeutics in The United States and Germany for Year 2013

  • Company report
  • June 2013
  • 17 pages

... Management reporting as reviewed by the senior management team in order to assess performance and allocate resources. The group is managed on a business segment basis rnai therapeutics and unallocated ...

  • Industries: Therapy
  • Countries: United States, Germany

Company Report: Therapy in The United States for Year 2013

  • Company report
  • June 2013
  • 3 pages
  • Industries: Therapy
  • Countries: United States

» Purchase Premium Reports (From $ 55 - $ 5 995)

About 5 900 reports
OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

  • $ 5 995
  • Industry report
  • March 2014
  • by Global Data

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “Oppo ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.